Jason Davis Biography and Net Worth

CFO of FibroBiologics

Jason D. Davis joined FibroBiologics as Chief Financial Officer in June 2025. He is a key member of the FibroBiologics executive leadership team and plays a critical role in the company’s strategic financial decision-making.

He most recently served as Chief Financial Officer of Virax Biolabs, where he helped navigate the company through its successful IPO in July 2022. During his tenure, he led multiple capital raises with favorable terms, managed all periodic reports and other filings with the SEC, and implemented public company governance best practices. Prior to Virax, he served in various finance roles for several public companies, where he raised capital in multiple transactions from U.S. and European capital markets.

He received his B.B.A. in Accounting from the University of Houston and is a CPA certified in Texas.

What is Jason Davis' net worth?: The estimated net worth of Jason Davis is at least $3.99 thousand as of March 2nd, 2026. Davis owns 3,500 shares of FibroBiologics stock worth more than $3,990 as of October 7th. This net worth evaluation does not reflect any other assets that Davis may own. Learn More about Jason Davis' net worth.
How do I contact Jason Davis?: The corporate mailing address for Davis and other FibroBiologics executives is 9350 Kirby Drive, Suite 300, Houston, TX, 77054. FibroBiologics can also be reached via phone at 281-671-5150 and via email at [email protected]. Learn More on Jason Davis' contact information.
Has Jason Davis been buying or selling shares of FibroBiologics?: Jason Davis has not been actively trading shares of FibroBiologics during the last ninety days. Most recently, on Monday, March 2nd, Jason Davis bought 3,500 shares of FibroBiologics stock. The stock was acquired at an average cost of $8.20 per share, with a total value of $28,700.00. Following the completion of the transaction, the chief financial officer now directly owns 3,500 shares of the company's stock, valued at $28,700. Learn More on Jason Davis' trading history.
Who are FibroBiologics' active insiders?: FibroBiologics' insider roster includes Jason Davis (CFO), and Hamid Khoja (Insider). Learn More on FibroBiologics' active insiders.
Are insiders buying or selling shares of FibroBiologics?: During the last year, FibroBiologics insiders bought shares 7 times. They purchased a total of 16,574 shares worth more than $120,485.80. The most recent insider tranaction occured on March, 4th when CEO Pete O'heeron bought 793 shares worth more than $6,026.80. Insiders at FibroBiologics own 7.3% of the company. Learn More about insider trades at FibroBiologics.
Information on this page was last updated on 3/4/2026.

Jason Davis Insider Trading History at FibroBiologics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
3/2/2026	Buy	3,500	$8.20	$28,700.00	3,500

Jason Davis Buying and Selling Activity at FibroBiologics

FibroBiologics Company Overview

FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. It holds 150+ U.S. and internationally issued patents/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, reversing organ involution, and cancer. FibroBiologics, Inc. was incorporated in 2021 and is based in Houston, Texas.

Today's Range

Now: $1.14

$1.07

$1.20

50 Day Range

MA: $1.32

$0.65

$2.11

2 Week Range

Now: $1.14

$0.62

$10.33

Volume

230,837 shs

Average Volume

250,388 shs

Market Capitalization

$7.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.72